| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1034 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B6-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
1996-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_417ccc7080018120f7bde63f6089cc84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c1a04300a2200c4a9bd8b7dfd508b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9209b1e469a5f47df3f12820931da0f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe5fd60f5e75a1e9f7951bbdcdf87c1a |
| publicationDate |
1998-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5792604-A |
| titleOfInvention |
Method of identifying MHC-class I restricted antigens endogenously processed by cellular secretory pathway |
| abstract |
A method of identifying antigens which are capable of being endogenously processed by a cellular secretory pathway comprising: introducing an antigen into a donor cell lacking in MHC class I molecules, incubating in an in vitro medium the donor cells, primed cytotoxic T lymphocytes having specificity for the antigen, and target cells which express MHC class I molecules and are labelled with a detectable intracellular marker, under suitable conditions such that the donor cells remain intact, and measuring the amount of detectable marker released into the incubation medium. A method of assaying a medium for the presence of a substance that affects processing of an endogenously processed antigen in a cellular secretory pathway, and; a method of characterizing a tumor or viral antigen capable of being endogenously processed by a cellular secretory pathway. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2568289-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2586461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2644701-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003035807-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003044420-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006018900-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003039659-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7084256-B2 |
| priorityDate |
1996-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |